Open access
Aug 2026
Harnessing necroptosis via RIPK1 degradation to potentiate radio-immunotherapy in cervical cancer
Immune checkpoint inhibitors (ICIs) are first-line therapy for cervical cancer (CC), yet their efficacy is limited to a subset of patients owing to low tumor immunogenicity. Single-cell RNA sequencing revealed that CC patients exhibiting robust immune responses following radiotherapy (RT) showed upregulation of necropt...
Tong Wu, Bin Lv, Han Wang et al.
· Bioactive Materials · 0 citations